1. Home
  2. NREF vs GALT Comparison

NREF vs GALT Comparison

Compare NREF & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NexPoint Real Estate Finance Inc.

NREF

NexPoint Real Estate Finance Inc.

HOLD

Current Price

$14.80

Market Cap

233.4M

Sector

Real Estate

ML Signal

HOLD

Logo Galectin Therapeutics Inc.

GALT

Galectin Therapeutics Inc.

HOLD

Current Price

$5.70

Market Cap

232.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NREF
GALT
Founded
2019
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
233.4M
232.3M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
NREF
GALT
Price
$14.80
$5.70
Analyst Decision
Hold
Strong Buy
Analyst Count
3
3
Target Price
$14.75
$6.00
AVG Volume (30 Days)
56.6K
352.1K
Earning Date
10-30-2025
11-14-2025
Dividend Yield
13.52%
N/A
EPS Growth
132.43
N/A
EPS
3.08
N/A
Revenue
$151,560,000.00
N/A
Revenue This Year
$27.88
N/A
Revenue Next Year
$5.41
N/A
P/E Ratio
$4.81
N/A
Revenue Growth
107.15
N/A
52 Week Low
$12.14
$0.73
52 Week High
$18.09
$6.55

Technical Indicators

Market Signals
Indicator
NREF
GALT
Relative Strength Index (RSI) 68.52 53.94
Support Level $14.22 $5.31
Resistance Level $14.57 $5.88
Average True Range (ATR) 0.31 0.47
MACD 0.10 -0.04
Stochastic Oscillator 96.18 48.36

Price Performance

Historical Comparison
NREF
GALT

About NREF NexPoint Real Estate Finance Inc.

NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Share on Social Networks: